Medidata (NASDAQ: MDSO) today announced that it will release its fourth quarter 2018 financial results before the market opens on Tuesday, February 12, 2019. The company will also hold a conference call at 8 a.m. ET for the investment community to discuss the company’s results and business outlook.
| Conference ID: | 9289627 | |||
| Live dial-in: | 1-877-303-2528, domestic | |||
| 1-847-829-0023, international | ||||
| Webcast: | investor.mdsol.com | |||
| Replay: | 1-855-859-2056, domestic | |||
| 1-404-537-3406, international | ||||
About Medidata
Medidata is leading the digital transformation of life sciences, with the world's most used platform for clinical development, commercial, and real-world data. Powered by artificial intelligence and delivered by the #1 ranked industry experts, the Intelligent Platform for Life Sciences helps pharmaceutical, biotech, medical device companies, and academic researchers accelerate value, minimize risk and optimize outcomes. Medidata serves more than 1,000 customers and partners worldwide and empowers more than 100,000 certified users every day to create hope for millions of patients. Discover the future of life sciences: www.medidata.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20190129005155/en/
Contacts:
Investors:
Betsy
Frank, 917-522-4620
bfrank@medidata.com
or
Media:
Erik
Snider, 646-362-2997
esnider@medidata.com
